Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Jun 1;18(11):3054-63.
doi: 10.1093/emboj/18.11.3054.

Excess beta-catenin promotes accumulation of transcriptionally active p53

A Damalas  1 , A Ben-Ze'ev, I Simcha, M Shtutman, J F Leal, J Zhurinsky, B Geiger, M Oren
Affiliations

Excess beta-catenin promotes accumulation of transcriptionally active p53

A Damalas et al. EMBO J. .

Abstract

beta-catenin is a multifunctional protein, acting both as a structural component of the cell adhesion machinery and as a transducer of extracellular signals. Deregulated beta-catenin protein expression, due to mutations in the beta-catenin gene itself or in its upstream regulator, the adenomatous polyposis coli (APC) gene, is prevalent in colorectal cancer and in several other tumor types, and attests to the potential oncogenic activity of this protein. Increased expression of beta-catenin is an early event in colorectal carcinogenesis, and is usually followed by a later mutational inactivation of the p53 tumor suppressor. To examine whether these two key steps in carcinogenesis are interrelated, we studied the effect of excess beta-catenin on p53. We report here that overexpression of beta-catenin results in accumulation of p53, apparently through interference with its proteolytic degradation. This effect involves both Mdm2-dependent and -independent p53 degradation pathways, and is accompanied by augmented transcriptional activity of p53 in the affected cells. Increased p53 activity may provide a safeguard against oncogenic deregulation of beta-catenin, and thus impose a pressure for mutational inactivation of p53 during the later stages of tumor progression.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8292-7 - PubMed
    1. Cell. 1998 Jun 26;93(7):1171-82 - PubMed
    1. Nature. 1998 Jul 2;394(6688):82-4 - PubMed
    1. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51 - PubMed
    1. Mol Med Today. 1998 Jun;4(6):250-6 - PubMed

Publication types

MeSH terms